NIH-funded research R21 grant

Natural products and oral bacteria in gum disease

Official title: Structures and functions of natural products in periodontal disease

Funded at Baylor College of Medicine · NIH-11367229 · Data updated 2026-11-12

Researchers are exploring how natural compounds from oral bacteria influence periodontal disease and how this could lead to targeted, microbiome-friendly treatments.

More Periodontal Disease research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine
NIH-funded
Lab location1 site (Houston, United States)
Project startJune 5, 2026
Project endJune 4, 2028
Funding year2026
Award (this year)$453,797
NIH project number1R21DE035210-01A1
Project IDNIH-11367229 on NIH RePORTER

Who could benefit from this research

Could help

Individuals with periodontal disease or at high risk due to oral microbiome imbalance.

Less likely to help

People without periodontal disease or those not affected by oral microbiome dysbiosis may not benefit.

What this research studies

This project aims to understand how natural molecules produced by oral bacteria affect periodontal disease and how they might be used to selectively control harmful bacteria without disrupting beneficial microbes. By studying microcins and other compounds, scientists hope to identify new, targeted therapies for periodontitis that could also reduce links to systemic health issues like atherosclerosis. The work combines microbiology, chemistry, and disease biology to uncover chemical leads from the human oral microbiome. The findings could pave the way for treatments that maintain a balanced oral ecosystem while preventing disease progression.

Why it matters

Potential benefit: If successful, patients could have more precise treatments for gum disease that spare healthy bacteria and potentially reduce risks for related systemic conditions.

How similar studies have gone: Previous work shows that microbiome-derived molecules can influence infection and colonization, supporting potential for targeted therapies.

Where this research is happening

  • Baylor College of Medicine
    Houston, United States
    Active

Researchers

  • Principal investigator: Johnston, Chad William — Baylor College of Medicine
  • Study coordinator: Johnston, Chad William

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.